Skip to main content
Clinical Trials/NCT02501044
NCT02501044
Completed
Not Applicable

Oxygen Desaturation During Hemodialysis: Clinical Correlates and Association With Adverse Outcomes

Renal Research Institute1 site in 1 country5,500 target enrollmentJanuary 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Renal Disease
Sponsor
Renal Research Institute
Enrollment
5500
Locations
1
Primary Endpoint
Cumulative number of deoxygenation episodes
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

Hemodialysis patients may experience drops in blood oxygen saturation during the hemodialysis treatment, which may lead to hypoxia in the tissues.

The investigators hypothesize that:

  1. The cumulative number, severity, or other characteristics of such deoxygenation episodes may be a predictor of adverse outcomes in hemodialysis patients.
  2. There may be demographic, anthropometric, clinical, treatment prescription, lab analytical, and other parameters that correlate with the number and severity of deoxygenation episodes and, therefore, may be used for risk stratification. Further, some of these parameters may be modifiable.
Registry
clinicaltrials.gov
Start Date
January 2012
End Date
January 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Hemodialysis patient

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Cumulative number of deoxygenation episodes

Time Frame: Up to 36 months

Crit-Line III monitor recordings (which contain oxygen saturation data) will be extracted from the RRI database and the cumulative number of deoxygenation episodes will be analyzed.

Study Sites (1)

Loading locations...

Similar Trials